New formulation of old aspirin for better delivery
- 16 October 2015
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 52 (1) , 140-143
Abstract
For better use of cyclooxygenase dependent anti-inflammatory properties and mitochondrial activities of aspirin, new hydrophobic analogues of aspirin were developed and successfully encapsulated in polymeric nanoparticles (NPs). In vivo anti-inflammatory effects of these NPs using a mouse model demonstrated unique properties of an optimized aspirin analogue to inhibit production of pro-inflammatory and enrichment of anti-inflammatory cytokines.Keywords
This publication has 25 references indexed in Scilit:
- Neuroprotective Effect of a New Synthetic Aspirin-decursinol Adduct in Experimental Animal Models of Ischemic StrokePLOS ONE, 2013
- Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeuticsProceedings of the National Academy of Sciences, 2012
- The Promise of Neuroprotective Agents in Parkinson?s DiseaseFrontiers in Neurology, 2011
- Inflammation in neurodegenerative diseasesImmunology, 2010
- Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseasesHuman Molecular Genetics, 2009
- Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actionsBlood, 2006
- Guidelines for the Early Management of Patients With Ischemic StrokeStroke, 2003
- Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitorsGut, 2003
- Acetaminophen distribution in the rat central nervous systemLife Sciences, 2001
- Acetylsalicylate (ASA)‐induced mitochondrial dysfunction and its potentiation by Ca2+Liver International, 1994